文献速递免疫规划传染病防控与疫情报告

8月龄儿童同时接种麻风联合减毒活疫苗与乙脑减毒活疫苗的免疫原性和安全性

[Immunogenicity and safety of concomitant inoculation of Measles and rubella combined live vaccine and Japanese encephalitis attenuated live vaccine].
PubMed 文献 · Zhonghua Yu Fang Yi Xue Za Zhi · 2021-01-01

在浙江省两市纳入504名8月龄健康儿童随机分组,比较麻风联合减毒活疫苗与乙脑减毒活疫苗同时接种(试验组)与麻风疫苗单独接种(对照组)的免疫原性和安全性。结果显示两组麻疹、风疹抗体阳转率和GMC均无统计学差异,试验组非劣效于对照组,未发现相关严重不良反应,一般反应为主且预后良好。

要点

  • 8月龄儿童同时接种麻风联合减毒活疫苗与乙脑减毒活疫苗具有良好免疫原性。
  • 试验组麻疹抗体阳转率96.43%、风疹抗体阳转率88.49%,非劣效于对照组。
  • 两组均未发生相关严重不良反应,不良反应发生率无统计学差异。

核心结论

  • 8月龄儿童同时接种麻疹风疹联合减毒活疫苗和乙型脑炎减毒活疫苗具有良好的安全性和免疫原性。
  • 试验组疫苗接种后麻疹、风疹抗体阳性率、阳转率非劣效于对照组。

研究设计与样本

  • 选定浙江省两市满8月龄健康儿童,随机分配至麻风联合减毒活疫苗和乙脑减毒活疫苗联合接种组(试验组)与麻风疫苗单独接种组(对照组)。
  • 共纳入符合方案的研究对象504名,试验组和对照组均为252名。
  • 接种前和接种后6周采集静脉血1 ml,采用ELISA测定麻疹、风疹IgG抗体,并评价安全性。

主要发现

  • 试验组同时接种后麻疹抗体阳性率98.41%,阳转率96.43%,GMC为1 539.94 mIU/ml;风疹抗体阳性率89.29%,阳转率88.49%,GMC为47.65 mIU/ml。
  • 对照组接种后麻疹抗体阳性率98.02%,阳转率97.62%,GMC为1 428.96 mIU/ml;风疹抗体阳性率86.51%,阳转率86.11%,GMC为45.66 mIU/ml。
  • 两组间GMC差异无统计学意义,试验组麻疹、风疹抗体阳性率和阳转率非劣效于对照组。
  • 两组均未发现相关严重不良反应事件,以一般反应为主且预后良好,两组不良反应发生率比较无统计学差异。

临床怎么用

  • 8月龄儿童可按免疫程序同时接种麻风联合减毒活疫苗和乙脑减毒活疫苗,无需担心免疫原性降低或安全性问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the immunogenicity and safety of concomitant inoculation of Measles and Rubella Combined Live-attenuated Japanese encephalitis vaccine. Methods: Healthy children aged 8 months in selected cities in Zhejiang Province were randomly assigned to the MR and JVE-L combined vaccination group (the experimental group), and the MR single vaccination group (the control group) was taken before the exemption and 6 weeks after the exemption. Peripheral venous blood 1 ml was used as serum antibody test for measles and rubella, and the levels of measles and rubella antibodies before and after vaccination were evaluated. The safety of combined vaccination was evaluated. Measles and rubella IgG antibodies were detected by enzyme-linked immunosorbent assay (ELISA). Data were double-entry with Epidata and statistical analysis was performed using Epi Info epidemiological statistical analysis software. Results: The results showed that no severe adverse event occurred in two groups, clinical reactions in each inoculation group were mild.The seroconversion rate of measles antibody and rubella antibody were 96.43% and 88.49% in the experimental group after vaccination, the geometrical mean concentrations(GMC) of measles antibody was 1 526.45 mIU/ml and the GMC of rubella antibody was 47.70 mIU/ml after concomitant inoculation; the seroconversion rate of measles antibody and rubella antibody were 97.62% and 86.11% in the control group, the GMC of Measles antibody was 1 392.28 mIU/ml and the GMC of Rubella antibody was 45.72 mIU/ml after MV inoculation. No difference were detected in two groups of seroconversion rate of measles antibody and rubella antibody and GMC after vaccination. Conclusion: The immunogenicity and safety is equivalent when MR and JVE-L were simultaneous inoculation. 目的: 分析浙江省8月龄儿童同时接种麻疹风疹联合减毒活疫苗和乙型脑炎减毒活疫苗的免疫原性和安全性。 方法: 选定浙江省两市满8月龄健康儿童,将儿童采用随机分组方法分配至麻疹风疹联合减毒活疫苗和乙型脑炎减毒活疫苗联合接种组(试验组),麻疹风疹联合减毒活疫苗单独接种组(对照组)。分别在疫苗接种前和疫苗接种后的6周采集儿童的静脉血1 ml,检测麻疹、风疹的血清中抗体浓度,评价疫苗接种前后的麻疹、风疹抗体水平;同时对联合接种的安全性进行评价。采用酶联免疫试验方法(ELISA)测定麻疹、风疹IgG抗体,分析同时接种麻疹风疹联合减毒疫苗和乙型脑炎减毒活疫苗的免疫原性和安全性。 结果: 共纳入符合方案的研究对象504名,其中试验组和对照组均为252名。试验组两种疫苗同时接种后麻疹抗体阳性率98.41%,阳转率96.43%,抗体几何平均浓度(GMC)为1 539.94 mIU/ml,疫苗接种后风疹抗体阳性率89.29%,阳转率88.49%,GMC为47.65 mIU/ml;对照组疫苗接种麻疹抗体阳性率98.02%,阳转率97.62%,GMC为1 428.96 mIU/ml,疫苗接种后风疹抗体阳性率86.51%,阳转率86.11%,GMC为45.66 mIU/ml,两组间GMC差异无统计学意义,试验组疫苗接种后麻疹、风疹抗体阳性率、阳转率非劣效于对照组。对研究对象接种疫苗后开展安全性观察,均具有较高的安全性,未发现相关严重不良反应事件,以一般反应为主,且预后良好。对试验组和对照组两组间的不良反应发生率进行比较,无统计学差异。 结论: 8月龄联合接种麻疹风疹减毒活疫苗和乙型脑炎减毒活疫苗具有良好的安全性和免疫原性。.

来源:Zhonghua Yu Fang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Tang XW, Yan R, Zhou Y, et al. [Immunogenicity and safety of concomitant inoculation of Measles and rubella combined live vaccine and Japanese encephalitis attenuated live vaccine]. Zhonghua Yu Fang Yi Xue Za Zhi. 2021. PMID: 34304419. doi:10.3760/cma.j.cn112150-20200713-01000

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。